Share
The Endocrine Society praised the American Medical Association’s House of Delegates for passing a resolution opposing efforts to criminalize medical care for transgender youth. The resolution, which cites the Endocrine Society’s Clinical Practice Guidelines on transgender care, makes it AMA policy to oppose the criminalization and otherwise undue restriction of evidence-based gender-affirming care. The Endocrine...
Share
As with most surgeries, venous thromboembolism is always a potential risk and transgender surgical procedures are no different. A new study published in The Journal of Clinical Endocrinology & Metabolism shows no increased clot risk while maintaining hormone therapy during gender affirming surgery. Transgender medicine continues to grow and evolve – more and more people...
Share
Medical evidence, not politics, should inform treatment decisions The Endocrine Society opposes legislative efforts that do not conform to medical evidence and clinical practice to prevent transgender and gender diverse adolescents from accessing gender-affirming medical care. Arkansas passed a law April 6 prohibiting gender-affirming care for minors, the first law of its kind in the U.S. Seventeen other states...
Share
A relatively new field, transgender medicine will be featured in the ENDO 2021 session, “Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition,” a live, 90-minute program taking place Sunday, March 21, 2021, at 12:15 p.m. Program co-chair, Stephen M. Rosenthal, MD, and Sabine Hannema, MD, PhD, talk to Endocrine News about what attendees can...
Share
A potentially dangerous side effect of testosterone therapy for transgender men is an increase in red blood cells that can raise the risk of blood clots, heart attack or stroke, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Gender diverse people make up an estimated 0.6% of the U.S. population...
Share
Case could determine future access to care for gender diverse youth The United Kingdom’s High Court has granted permission for a coalition of LGBTQ+, youth, reproductive health and medical organizations, including the Endocrine Society, to intervene in an appeal of its decision that minors under age 16 likely could not give informed consent for pubertal...
Share
The Endocrine Society and the Pediatric Endocrine Society oppose legislative efforts to block transgender and gender diverse individuals from accessing gender-affirming medical and surgical care, the two medical societies said in a joint policy perspective published in The Journal of Clinical Endocrinology & Metabolism. In the past three years, legislators in 17 states have proposed more than two dozen bills barring medical and surgical treatments for transgender and gender diverse youth and adults. Many of these bills reflect widespread...
Share
The Endocrine Society is an advocate for transgender patients and ensuring their access to gender-affirming, evidence-based healthcare. During the Fall, the Society’s Transgender Special Interest Group and members of the Pediatric Endocrine Society formed a working group to update Society documents and develop new material on care for transgender individuals to be used in advocacy...
